Mucormycosis in COVID-19 patients
- PMID: 34827032
- PMCID: PMC8837345
- DOI: 10.4103/ijo.IJO_1316_21
Mucormycosis in COVID-19 patients
Abstract
Mucormycosis, commonly known as 'Black Fungus' which was then a rare fungal infection, has suddenly come to light post the COVID-19- pandemic, more so during the second wave in India. It thus becomes important not only for the medical fraternity but also the general population to build awareness about the same. The present review will focus on the pathophysiology, etiology, outcomes of some case studies, and current treatment methods of mucormycosis infection. Major focus of the current article is on rhino-orbital-cerebral mucormycosis. All the studies included in the present review article was extracted from the PubMed database.
Keywords: COVID-19; Corticosteroids; diabetes; hyperglycemia; immunosuppression; ketoacidosis; mucormycosis; rhino-orbital-cerebral mucormycosis.
Conflict of interest statement
None
References
-
- Nishanth DG, Anitha DN, Babu DNA, Malathi DL. Mucormycosis - A review. Eur J Mol Clin Med. 2020;7:1786–91.
-
- Ajith Kumar AK, Gupta V. StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. Rhino-orbital cerebral mucormycosis. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
